Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07448415
PHASE2/PHASE3

Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma

Sponsor: Assiut University

View on ClinicalTrials.gov

Summary

In this study, the investigators evaluate the potential efficacy of TXA alone and microneedling assisted with glutathione alone versus combination of oral tranexamic acid and glutathione-assisted microneedling in the treatment of melasma

Official title: Evaluation of the Efficacy and Safety of Oral Tranexamic Acid Combined With Glutathione-assisted Microneedling Versus Each Therapy Alone in the Treatment of Melasma

Key Details

Gender

FEMALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

42

Start Date

2026-02

Completion Date

2027-04

Last Updated

2026-03-04

Healthy Volunteers

No

Conditions

Interventions

DEVICE

microneedling

with one ml of topical glutathione will be done in group A and B, three consecutive sessions, will be performed by derma pen with 36 needles head, will adjusted 1.5 mm needle length and will moved on stretched skin in four directions several times till erythema and pinpoint developed before and after topical application of GTH.

DRUG

Oral tranexamic acid

The patient will take oral tranexamic acid 250mg twice daily for 3 months

OTHER

Glutathione

investigators will use topical GSH solution in assist with microneedling to treat melasma